The Future of Pharma Marketing One to Five Years Out
HAP Innovations’ spencer Can Help Deliver 90% Adherence Rates
The Secret Behind Doximity’s Quick Growth
Point of Care, DTC: Precision Customer Engagement
Stop Calling it a “Patient Journey”—Patients Are Social Beings
In Patient Advocacy,“Grassroots” Means Meeting People Face to Face
Medical News
A Little Direction for New Creative Directors
There’s no instruction manual for leading a creative team at a marketing agency and ...
Are We Reaching the End of the Line for PBM Exclusion Lists?
In the rapidly evolving U.S. healthcare landscape, the pharmacy benefit manager (PBM) exclusion lists ...
Your Drug Landed on a Formulary Exclusion List: Where Do You Go From Here?
As a pharmaceutical marketer, you know the chance of your drug being on a ...
PM360 Q & A with Ron Caporale, CEO, Lifescript
Ron Caporale started his career at Goldman Sachs, but with an interest and background ...
Current and Future Use of HEOR Data in Decision Making
The growing power of payers in healthcare decision-making has put an increased emphasis on ...
Breaking Down Barriers and Forging Connectivity
There are many reasons that people dedicate their professional lives to the healthcare, pharma, ...
Digital Innovation Arrives at City Subways
While commuting on the New York City mass transit system, my attention is inevitably ...
Are We Reaching the End of the Line for PBM Exclusion Lists?
In the rapidly evolving U.S. healthcare landscape, the pharmacy benefit manager (PBM) exclusion lists ...
Current and Future Use of HEOR Data in Decision Making
The growing power of payers in healthcare decision-making has put an increased emphasis on ...
A Little Direction for New Creative Directors
There’s no instruction manual for leading a creative team at a marketing agency and ...
My Other Life with Davidek Herron
PM360 recently spoke to Davidek Herron, MBA, Head of Field Experience, Specialty Medicines at ...
